Swixx BioPharma is a leading pharmaceutical company committed to creating healthier futures for all. Founded in 2014, we specialize in providing modern medicines and healthcare solutions in Central and Eastern Europe (CEE) and beyond. With our expansion, Swixx BioPharma has become a trusted partner with the highest standards in the areas where we operate.

Our mission is to ensure that everyone has access to the best medical solutions for a healthier and better life. Though we don't have our own portfolio or research and development, we strive to maintain the standards and culture of a multinational pharmaceutical company. Our team of highly experienced professionals, with backgrounds in specialty pharmaceuticals, joined forces to fulfill our mission of providing access to the latest medicines from our partners.

With more than 1,200 employees, we are currently present in 23 countries and serve a population of over 335 million. In 2022, we achieved sales of over 700 million euros in the 53. 9 billion euro pharma market.

Our vision is to be the partner of choice for biopharma companies seeking an indirect route to market, ultimately improving patient outcomes. By working closely with our partners and healthcare communities, we aim to unlock access to innovative treatments for patients in need. Through our professional and collaborative relationships, we strive to make a meaningful and lasting impact on the health of individuals and communities in the countries where we operate.

At Swixx BioPharma, our leadership team consists of experienced professionals who understand the needs of the biopharma industry. With their deep industry knowledge and expertise, we are able to provide best-in-class pharma services. Join us as we continue our journey to create a healthier future for all, one modern medicine at a time